Global Atherosclerosis Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drug Class ;

Anti-platelet Medications, Cholesterol Lowering Medications, Fibric Acid and Omega-3 Fatty Acid Derivatives, Beta Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Diuretics and Others.

Segmented by Distribution Channel;

Retail Pharmacies, Hospital Pharmacies and Online Pharmacies.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn116464795 Published Date: March, 2024 Updated Date: April, 2024

Introduction

Global Atherosclerosis Drugs Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 51.3
2021 60.9
2022 61.7
2023 66.3
2024 79.3
2025 93.7
2026 97.8
2027 100.9
2028 114.0
2029 118.1
2030 137.4

In the year 2023, the Global Atherosclerosis Drugs Market was valued at USD 52,001.57 million. The size of this market is expected to increase to USD 61,813.52 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 2.5%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Distribution Channel
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Atherosclerosis Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increase in Prevalence of Atherosclerosis & Cardiovascular Diseases
        2. Development of New Treatments
        3. Rising Awareness about Cardiovascular Diseases
      2. Restraints
        1. Availability of Generic Products
        2. Low Diagnostic Rate
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Atherosclerosis Drugs Market, By Drug Class , 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Anti-platelet Medications
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Cholesterol Lowering Medications
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Fibric Acid and Omega-3 Fatty Acid Derivatives
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Beta Blockers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Angiotensin-Converting Enzyme (ACE) Inhibitors
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Calcium Channel Blockers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        7. Diuretics
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        8. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Atherosclerosis Drugs Market, By Distribution Channel, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Retail Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Hospital Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Online Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Atherosclerosis Drugs Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. GlaxoSmithKline Plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Hoffmann-La Roche Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Bayer AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Merck & Co., Inc. (Merck Sharp & Dohme Corp)
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Mylan N.V.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Amgen Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Atipamezole
Global Atipamezole Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Atipamezole Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Auto-injectors
Global Auto-Injectors Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Auto-Injectors Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Autoimmune and Inflammatory Immunomodulators
Global Autoimmune and Inflammatory Immunomodulators Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Autoimmune and Inflammatory Immunomodulators Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Autoimmune Drugs
Global Autoimmune Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Autoimmune Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...